Search: onr:"swepub:oai:lup.lub.lu.se:b73142b0-8b2a-4093-9eea-279f0e895e9b" >
Identification of B...
Identification of BIRC6 as a novel intervention target for neuroblastoma therapy
-
Lamers, Fieke (author)
-
Schild, Linda (author)
-
Koster, Jan (author)
-
show more...
-
Speleman, Frank (author)
-
- Øra, Ingrid (author)
- Lund University,Lunds universitet,Pediatrik, Lund,Sektion V,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Paediatrics (Lund),Section V,Department of Clinical Sciences, Lund,Faculty of Medicine
-
Westerhout, Ellen M. (author)
-
van Sluis, Peter (author)
-
Versteeg, Rogier (author)
-
Caron, Huib N. (author)
-
Molenaar, Jan J. (author)
-
show less...
-
(creator_code:org_t)
- 2012-07-12
- 2012
- English.
-
In: BMC Cancer. - : Springer Science and Business Media LLC. - 1471-2407. ; 12
- Related links:
-
https://portal.resea... (primary) (free)
-
show more...
-
http://dx.doi.org/10... (free)
-
https://bmccancer.bi...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- Background: Neuroblastoma are pediatric tumors of the sympathetic nervous system with a poor prognosis. Apoptosis is often deregulated in cancer cells, but only a few defects in apoptotic routes have been identified in neuroblastoma. Methods: Here we investigated genomic aberrations affecting genes of the intrinsic apoptotic pathway in neuroblastoma. We analyzed DNA profiling data (CGH and SNP arrays) and mRNA expression data of 31 genes of the intrinsic apoptotic pathway in a dataset of 88 neuroblastoma tumors using the R2 bioinformatic platform (http://r2.amc.nl). BIRC6 was selected for further analysis as a tumor driving gene. Knockdown experiments were performed using BIRC6 lentiviral shRNA and phenotype responses were analyzed by Western blot and MTT-assays. In addition, DIABLO levels and interactions were investigated with immunofluorescence and co-immunoprecipitation. Results: We observed frequent gain of the BIRC6 gene on chromosome 2, which resulted in increased mRNA expression. BIRC6 is an inhibitor of apoptosis protein (IAP), that can bind and degrade the cytoplasmic fraction of the pro-apoptotic protein DIABLO. DIABLO mRNA expression was exceptionally high in neuroblastoma but the protein was only detected in the mitochondria. Upon silencing of BIRC6 by shRNA, DIABLO protein levels increased and cells went into apoptosis. Co-immunoprecipitation confirmed direct interaction between DIABLO and BIRC6 in neuroblastoma cell lines. Conclusion: Our findings indicate that BIRC6 may have a potential oncogenic role in neuroblastoma by inactivating cytoplasmic DIABLO. BIRC6 inhibition may therefore provide a means for therapeutic intervention in neuroblastoma.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Keyword
- Neuroblastoma
- BIRC6
- DIABLO
- Apoptosis
- Cancer
Publication and Content Type
- art (subject category)
- ref (subject category)
Find in a library
-
BMC Cancer
(Search for host publication in LIBRIS)
To the university's database
- By the author/editor
-
Lamers, Fieke
-
Schild, Linda
-
Koster, Jan
-
Speleman, Frank
-
Øra, Ingrid
-
Westerhout, Elle ...
-
show more...
-
van Sluis, Peter
-
Versteeg, Rogier
-
Caron, Huib N.
-
Molenaar, Jan J.
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cancer and Oncol ...
- Articles in the publication
-
BMC Cancer
- By the university
-
Lund University